Team:UCL/about
From 2014.igem.org
(Difference between revisions)
Lewismoffat (Talk | contribs) |
Adamdenyer (Talk | contribs) |
||
(9 intermediate revisions not shown) | |||
Line 20: | Line 20: | ||
</div> | </div> | ||
- | + | <div class="container clearfix" id="main-content"> | |
<!--begin main content--> | <!--begin main content--> | ||
- | + | ||
<div class="row-fluid sidebar-right"> | <div class="row-fluid sidebar-right"> | ||
Line 28: | Line 28: | ||
<div class="span9 primary-column"> | <div class="span9 primary-column"> | ||
<!--begin primary content--> | <!--begin primary content--> | ||
+ | |||
<h2>Project Overview</h2> | <h2>Project Overview</h2> | ||
<h4>The Problem: Azo Dyes in the Environment</h4> | <h4>The Problem: Azo Dyes in the Environment</h4> | ||
Line 40: | Line 41: | ||
<figcaption></figcaption> | <figcaption></figcaption> | ||
</figure></p> | </figure></p> | ||
+ | |||
<h4>Implementation in Industry</h4> | <h4>Implementation in Industry</h4> | ||
Line 50: | Line 52: | ||
<h4>Recycling Azo Dyes</h4> | <h4>Recycling Azo Dyes</h4> | ||
- | <p>Depending on the azo dye that is being degraded, different sets of breakdown products can be produced. Once degraded, each of the different compounds will be identified and separated. We have three potential avenues for re-using these products: (1) converting functional groups on the aromatic amines into simple aromatic fragrances; (2) isolating and diverting nitrogenous compounds to algae, which can form, and maintain, a symbiotic relationship with the dye-degrading <em>E. coli</em> hosts; (3) selling more complex compounds to pharmaceutical companies for the production of drugs. | + | <p>Depending on the azo dye that is being degraded, different sets of breakdown products can be produced. Once degraded, each of the different compounds will be identified and separated. We have three potential avenues for re-using these products: (1) converting functional groups on the aromatic amines into simple aromatic fragrances; (2) isolating and diverting nitrogenous compounds to algae, which can form, and maintain, a symbiotic relationship with the dye-degrading <em>E. coli</em> hosts; (3) selling more complex compounds to pharmaceutical companies for the production of drugs.</p> |
- | |||
- | |||
- | |||
- | |||
</div> | </div> | ||
<!-- close span9 primary-column--> | <!-- close span9 primary-column--> | ||
</html> | </html> | ||
- | {{:Team:UCL/Template:about-rhnav}} | + | {{:Team:UCL/Template:about-rhnav}} |
- | <html> | + | <html> |
</div> | </div> | ||
Line 67: | Line 65: | ||
</div> | </div> | ||
<!--close .container id="main-content" --> | <!--close .container id="main-content" --> | ||
+ | |||
</html> | </html> | ||
{{:Team:UCL/Template:pagefooter}} | {{:Team:UCL/Template:pagefooter}} |
Latest revision as of 15:07, 5 September 2014